Renovos Biologics

Renovos is a regenerative medicine company and the leading developer of RENOVITE® medical synthetic nanoclay. Renovos' patented RENOVITE® technology, originating from research at the University of Southampton in the UK, significantly enhances the performance of a range of regenerative medicine products, with its primary focus on orthopedic biologics. RENOVITE® introduces a novel mechanism of action, providing unprecedented retention of therapeutic agents at the target site of repair, confining its effect to a precisely controlled area. This results in a leap forward in efficacy, safety, and ease of use in both biodegradable and injectable formulations, making it suitable for minimally invasive applications.